Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.12−0.06 (-2.75%)
Close on Nov 19, 2026Market cap $101.23MP/E –Yield –
Minerva Neurosciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2022 it was -$24.66M, down 911.1% from the year before.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$24.66M | -911.1% |
| FY2017 | Dec 31, 2017 | $3.04M | – |
| FY2014 | Dec 31, 2014 | -$36.01M | – |
| FY2013 | Dec 31, 2013 | -$2.16M | – |
See a number that looks wrong?